In the present study, we evaluate the BP autoAb levels in 100 Chinese patients with stroke and 100 unaffected controls, demonstrating that BP autoantibodies are detectable at a higher frequency in stroke patients relative to unaffected controls (14 vs. 5%) and they react with human cutaneous BP180 and BP180-NC16A. This evidence concerns the gene COL17A1 and stroke disorder.